The Continuous Glucose Monitoring Devices Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size of continuous glucose monitoring devices has expanded substantially in the recent past. It is expected to progress from $8.41 billion in 2024 to $9.86 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 17.22%.
The Continuous Glucose Monitoring Devices Global Market is anticipated to reach $18.45 billion by 2029, with a compound annual growth rate (CAGR) of 16.96%.
Download Your Free Sample of the 2025 Continuous Glucose Monitoring Devices Market Report and Uncover Key Trends Now!The key drivers in the continuous glucose monitoring devices market are:
•An increase in healthcare spending globally
•Growing awareness about diabetes and its management
•Rising prevalence of diabetes worldwide
•Enhanced popularity and adoption of continuous glucose monitoring devices
The continuous glucose monitoring devices market covered in this report is segmented –
1) By Component: Transmitters, Sensors, Receivers
2) By Connectivity: Bluetooth, 4G
3) By Demography: Child Population, Adult Population
4) By Application: Gestational Diabetes, Type-2 Diabetes, Type-1 Diabetes
5) By End-Use: Hospitals, Homecare Settings, Other End Users
Subsegments:
1) By Transmitters: Bluetooth-Enabled Transmitters, Wireless Transmitters, Integrated Transmitter-Receiver Systems
2) By Sensors: Enzyme-Based Sensors, Electrochemical Sensors, Non-Invasive Sensors
3) By Receivers: Mobile Device Integration (Smartphone Receivers), Standalone Receivers, Cloud-Based Data Sync Receivers
The key trends in the continuous glucose monitoring devices market are:
•Technological advancements and new innovations are playing a crucial role in shaping the future of the continuous glucose monitoring device market.
•Mergers and acquisitions within the industry is a notable trend.
•The market will increasingly be influenced by regulatory approvals.
•Partnerships and collaborations among industry players is an emerging trend.
Major players in the continuous glucose monitoring devices market are:
• Johnson & Johnson
• F. Hoffmann-La Roche AG
• Sanofi S.A.
• Abbott Laboratories
• Medtronic Public Limited Company
• Novo Nordisk A/S
• Becton Dickinson and Company
• A. Menarini Diagnostics S.r.l.
• Dexcom Inc.
• Bionime Corporation
• Insulet Corporation
• Ascensia Diabetes Care Holdings AG
• Tandem Diabetes Care Inc.
• i-Sens Inc.
• Senseonics Holdings Inc.
• Medtrum Technologies Inc.
• Biolinq Inc.
• GlySens Incorporated
• Glucotrack Inc.
• Nemaura Medical Inc.
North America was the largest region in the continuous glucose monitoring devices market in 2024